Connection

RADEK SKODA to Leukemia, Myeloid, Acute

This is a "connection" page, showing publications RADEK SKODA has written about Leukemia, Myeloid, Acute.
Connection Strength

0.710
  1. Dual roles of EZH2 in acute myeloid leukemia. J Exp Med. 2019 04 01; 216(4):725-727.
    View in: PubMed
    Score: 0.420
  2. Genomic profiling for clinical decision making in?myeloid neoplasms and acute leukemia. Blood. 2022 11 24; 140(21):2228-2247.
    View in: PubMed
    Score: 0.135
  3. Hereditary thrombocytosis not as innocent as thought? Development into acute leukemia and myelofibrosis. Blood. 2010 Oct 28; 116(17):3375-6.
    View in: PubMed
    Score: 0.059
  4. NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? Leukemia. 2008 Jul; 22(7):1459-63.
    View in: PubMed
    Score: 0.048
  5. Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches. Proc Natl Acad Sci U S A. 2021 10 05; 118(40).
    View in: PubMed
    Score: 0.031
  6. JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report. Acta Haematol. 2013; 129(1):23-5.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.